{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:21:00Z","timestamp":1754162460299,"version":"3.41.2"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejmg.2025.105022","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T18:44:30Z","timestamp":1748371470000},"page":"105022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Wolcott-Rallison syndrome \u2013 crosstalk between PERK- EIF2A and type II interferon signaling"],"prefix":"10.1016","volume":"76","author":[{"given":"Megha","family":"Konduri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devin","family":"Boe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Yazigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brant R.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blachy Davila","family":"Saldana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Cavener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskar","family":"Kallakury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cal","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3312-112X","authenticated-orcid":false,"given":"Udeme D.","family":"Ekong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejmg.2025.105022_bib1","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1172\/JCI43157","article-title":"Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice","volume":"121","author":"Behrens","year":"2011","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.ejmg.2025.105022_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejmg.2025.105022_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.trsl.2016.07.023","article-title":"Use of a mouse model to identify a blood biomarker for IFNgamma activity in pediatric secondary hemophagocytic lymphohistiocytosis","volume":"180","author":"Buatois","year":"2017","journal-title":"Transl. Res."},{"issue":"12","key":"10.1016\/j.ejmg.2025.105022_bib4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.tem.2010.08.005","article-title":"PERK in beta cell biology and insulin biogenesis","volume":"21","author":"Cavener","year":"2010","journal-title":"Trends Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.ejmg.2025.105022_bib5","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.2020009499","article-title":"T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis","volume":"137","author":"Chaturvedi","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejmg.2025.105022_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13052-016-0262-7","article-title":"Comparison of Th1\/Th2 cytokine profiles between primary and secondary haemophagocytic lymphohistiocytosis","volume":"42","author":"Chen","year":"2016","journal-title":"Ital. J. Pediatr."},{"issue":"3","key":"10.1016\/j.ejmg.2025.105022_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1182\/blood.2021013549","article-title":"Expansion of CD4dimCD8+ T cells characterizes macrophage activation syndrome and other secondary HLH","volume":"140","author":"De Matteis","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ejmg.2025.105022_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269553","article-title":"Familial hemophagocytic lymphohistiocytosis hepatitis is mediated by IFN-gamma in a predominantly hepatic-intrinsic manner","volume":"17","author":"Diamond","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejmg.2025.105022_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39601-9","article-title":"CXCL9 inhibition does not ameliorate disease in murine models of both primary and secondary hemophagocytic lymphohistiocytosis","volume":"13","author":"Diamond","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejmg.2025.105022_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13082","article-title":"World's smallest combined en bloc liver-pancreas transplantation","volume":"22","author":"Elsabbagh","year":"2018","journal-title":"Pediatr. Transplant."},{"issue":"8","key":"10.1016\/j.ejmg.2025.105022_bib11","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2337\/db09-1064","article-title":"PERK (EIF2AK3) regulates proinsulin trafficking and quality control in the secretory pathway","volume":"59","author":"Gupta","year":"2010","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ejmg.2025.105022_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000369804","article-title":"Liver disease and other comorbidities in Wolcott-Rallison syndrome: different phenotype and variable associations in a large cohort","volume":"83","author":"Habeb","year":"2015","journal-title":"Horm. Res. Paediatr."},{"issue":"2","key":"10.1016\/j.ejmg.2025.105022_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.ejmg.2025.105022_bib14","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.clml.2018.08.017","article-title":"Hemophagocytic lymphohistiocytosis in a patient with multiple myeloma","volume":"19","author":"Hsu","year":"2019","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"1","key":"10.1016\/j.ejmg.2025.105022_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.1302282","article-title":"Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis","volume":"192","author":"Johnson","year":"2014","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.ejmg.2025.105022_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ejmg.2025.105022_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27929","article-title":"Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American consortium for histiocytosis (NACHO)","volume":"66","author":"Jordan","year":"2019","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ejmg.2025.105022_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1172-5-29","article-title":"Wolcott-Rallison syndrome","volume":"5","author":"Julier","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"issue":"17","key":"10.1016\/j.ejmg.2025.105022_bib19","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1182\/bloodadvances.2021004287","article-title":"IFN-gamma signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS","volume":"5","author":"Lin","year":"2021","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.ejmg.2025.105022_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/pbc.24188","article-title":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab","volume":"60","author":"Marsh","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"issue":"3","key":"10.1016\/j.ejmg.2025.105022_bib21","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/TP.0000000000002869","article-title":"First European case of simultaneous liver and pancreas transplantation as treatment of wolcott-rallison syndrome in a small child","volume":"104","author":"Nordstrom","year":"2020","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.ejmg.2025.105022_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226043","article-title":"The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis","volume":"14","author":"Prencipe","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejmg.2025.105022_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/lt.24402","article-title":"En bloc multiorgan transplant (liver, pancreas, and kidney) for acute liver and renal failure in a patient with Wolcott-Rallison syndrome","volume":"22","author":"Rivera","year":"2016","journal-title":"Liver Transpl"},{"issue":"14","key":"10.1016\/j.ejmg.2025.105022_bib24","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1074\/jbc.M117.813790","article-title":"The protein kinase PERK\/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones","volume":"293","author":"Sowers","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejmg.2025.105022_bib25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1365-2249.2003.02237.x","article-title":"Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis","volume":"133","author":"Takada","year":"2003","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.ejmg.2025.105022_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2141.2008.07298.x","article-title":"Early diagnostic and prognostic significance of a specific Th1\/Th2 cytokine pattern in children with haemophagocytic syndrome","volume":"143","author":"Tang","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.ejmg.2025.105022_bib27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/ajt.13005","article-title":"Liver, pancreas and kidney transplantation for the treatment of Wolcott-Rallison syndrome","volume":"15","author":"Tzakis","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"47","key":"10.1016\/j.ejmg.2025.105022_bib28","doi-asserted-by":"crossref","first-page":"33824","DOI":"10.1074\/jbc.M113.503664","article-title":"Insulin secretion and Ca2+ dynamics in beta-cells are regulated by PERK (EIF2AK3) in concert with calcineurin","volume":"288","author":"Wang","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejmg.2025.105022_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/jcp.21543","article-title":"PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation","volume":"217","author":"Wei","year":"2008","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.ejmg.2025.105022_bib30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0022-3476(72)80596-1","article-title":"Infancy-onset diabetes mellitus and multiple epiphyseal dysplasia","volume":"80","author":"Wolcott","year":"1972","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.ejmg.2025.105022_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cmet.2006.11.002","article-title":"PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for postnatal glucose homeostasis","volume":"4","author":"Zhang","year":"2006","journal-title":"Cell Metab."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721225000291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721225000291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T07:28:26Z","timestamp":1753860506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721225000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":31,"alternative-id":["S1769721225000291"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2025.105022","relation":{},"ISSN":["1769-7212"],"issn-type":[{"type":"print","value":"1769-7212"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wolcott-Rallison syndrome \u2013 crosstalk between PERK- EIF2A and type II interferon signaling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2025.105022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105022"}}